Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
-1.99%
+0.14%
-3.06%
MNKD
MannKind
$5.49
Login to see MannKind (MNKD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Earnings are forecast to grow
Chart
$5.57 (-1.44%)
$3.77 (+45.62%)
$4.72 (+16.31%)
$6.6 (-16.82%)
MNKD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
MNKD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
MNKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNKD Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayMNKD Earnings
The TTM reflects 12-month period, providing review of MNKD financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is MNKD current stock price?
What are MNKD stock strengths?
What risks are associated with MNKD stock?
When is MNKD next earnings report?
What is MNKD market cap and volume?
What is MNKD's current Stock IQ?
Should I buy MNKD stock right now?
Is MNKD a Strong Buy right now?
What does a 'Strong Buy' rating mean for MNKD?
What does a 'Strong Sell' rating mean for MNKD?
What factors influence MNKD's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.32%
-1.99%
+0.14%
-3.06%
MNKD
MannKind
Current Price
$5.49
Stock Insights
Strengths
Upgraded on attractively valued
Earnings are forecast to grow
Login to unlock MannKind (MNKD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$5.57 (-1.44%)
$3.77 (+45.62%)
$4.72 (+16.31%)
$6.6 (-16.82%)
MNKD Analysts Opinion
MNKD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
MNKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNKD Street view is extremely bullish and have negative views on the near-term outlook
MNKD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayMNKD Earnings
The TTM data reflects the most recent 12-month period, providing overview of MNKD financial performance.
MNKD Financial Health
The company financial health has moderately improved over the past year
Financial Score
MNKD Latest Analysis
MannKind Appoints Ajay Ahuja As CMO . (RTTNews) - MannKind Corp. (MNKD) a biopharmaceutical company on Monday announced that it has appointed Ajay Ahuja as Chief Medical Officer with immediate effect.
Mon Sep 29, 2025
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer. WESTLAKE VILLAGE Calif. Sept. 29 2025 (GLOBE NEWSWIRE) -- )Ajay'.s deep expertise in medical affairs clinical development and global strategy—combined with his background as a practicing physician—will be instrumental as we continue to advance our pipeline and expand our impact in endocrine and orphan lung diseases said Dr. Castagna. In particular his experience in the cardiometabolic area will be instrum
Mon Sep 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MNKD Stock trends
MNKD Stock performance
MNKD Stock analysis
MNKD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings